<DOC>
	<DOCNO>NCT01212614</DOCNO>
	<brief_summary>This study base successfully complete project SNF 320000-112006 ( EK 1152 SwissMedic 2005dr2207e ) document physiological effect inhibit gastric secretion volume well acidity gastric secretion high dose proton pump inhibitor GERD patient healthy control . Twelve participant group study randomize , double-blind placebo control trial . A novel non-invasive MRI technique develop Zurich ass volume gastric secretion follow ingestion regular liquid meal . In addition , intragastric / esophageal pH monitor assess link volume intragastric distribution gastric secretion reflux event symptom . In addition , effect gastric secretion outcome parameter non-invasive stable isotope breath test measurement gastric empty assess .</brief_summary>
	<brief_title>Measurement Gastric Secretion MRI Under Inhibition ProtonPump Inhibitors Healthy Subjects &amp; GERD Patients</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<criteria>Inclusion criterion : Healthy volunteer must less one episode reflux dyspeptic symptom per month mild severity last 3 month Reflux patient ( GERD ) must chronic symptom ( &gt; 8 week ) suggestive GERD ( definition questionnaire see Appendix page 30 ) . In addition , initial screen manometry must show severe esophageal dysmotility ( e.g . spasm , achalasia ) . If addition pHstudy perform acid exposure must &gt; 4.2 % / 24h . Exclusion criterion : Age 18 65 Pathologic underweight overweight ( BMI &lt; 18 &gt; 30 kg/m2 ) Previous history gastrointestinal disease surgery ( excludes appendectomy , cholecystectomy , hernia repair anorectal disorder ) Previous cardiorespiratory ( excludes arterial hypertension ) , hematologic , renal , atopic , alimentary psychiatric disease , diabetes , drug alcohol abuse Patient unable stop medication alters gut function 72 hour prior study , include anticholinergic , prokinetics , protonpump inhibitor , nonsteroidal antiinflammatory drug Positive Helicobacter pylorus status 13CUrea breath test Presence metallic implant , device metallic foreign body Pregnancy lactation ( female patient child bear age receive pregnancy test prior study ) Female volunteer without adequate contraception duration study Involvement clinical trial course trial , within period 30 day prior begin 30 day completion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>